Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826)
Clinical trial NCT03662191 · COMPLETED
Trial details
- NCT number
- NCT03662191
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-28
- Primary completion
- 2019-01-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.